• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Brain-interface tech startup Paradromics raises $7m in seed funding

Brain-interface tech startup Paradromics raises $7m in seed funding

June 11, 2018 By Fink Densford

Paradromics

Medtech startup Paradromics said today it raised $7 million in seed round funding to help support its brain-machine interface technology intended to allow patients with severe connectivity disorders to operate advanced prosthetic devices.

The San Jose, Calif.-based company is developing brain-machine interface tech intended to allow patients with disorders including blindness, deafness and paralysis to connect to the world with advanced prosthetics. An initial focus of the system will be allowing patients who are unable to communicate fluently to be able to speak in real time with the aid of a computer.

“We are developing our technology to power the next wave of neural interfacing medical devices — from advanced prosthetics to bioelectronic medicine. The high-bandwidth feature of our technology has revolutionary implications for the field of neuro-prosthetics and beyond. The financial backing and strategic expertise of our investors will help us expand the team, grow the IP portfolio and more rapidly execute our technical development plan,” founder & CEO Matt Angle said in a prepared statement.

The round was led by newly invested Arkitekt Ventures and Synergy Ventures and joined by It-Farm, Dolby Ventures, Alphon Edison, Loup Ventures and previously invested Fusion Fund, Paradromics said.

As part of the funding round, Arkitekt Ventures managing director Enke Bashllari will join the company’s board of directors.

“We are thrilled to back this team of leading scientists and engineers. They are fundamentally changing the way that humans and computers will interact and are opening the door to a whole new field of medicine. The future of BMI goes way beyond conventional prosthetics. Soon, we will address brain diseases not only via a small molecule or biologics, but via targeted electrical signals. Closed loop systems that enable high bandwidth interfacing of the cortex with the outside world (and vice-versa) will radically improve patients’ lives,” Bashllari said in a press release.

Funds raised will be added to approximately $18 million the company received in research funding from the Defense Advances Research Projects Agency won as part of DARPA’s Neural Engineering System Design program.

Filed Under: Business/Financial News, Neurological Tagged With: paradromics

More recent news

  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • GE HealthCare taps retiring AT&T CFO for board of directors
  • Corcym delivers first-in-human implant of Memo 4D Curve mitral repair ring
  • Boston Scientific MedSurg, Asia Pacific leader to retire
  • DePuy Synthes launches next-generation automated fracture fixation system

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy